These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10583160)

  • 1. Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors.
    Powell TJ; Ben-Bassat H; Klein BY; Chen H; Shenoy N; McCollough J; Narog B; Gazit A; Harzstark Z; Chaouat M; Levitzki R; Tang C; McMahon J; Shawver L; Levitzki A
    Br J Dermatol; 1999 Nov; 141(5):802-10. PubMed ID: 10583160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of tyrosine kinases in the treatment of psoriasis.
    Ben-Bassat H; Klein BY
    Curr Pharm Des; 2000 Jun; 6(9):933-42. PubMed ID: 10828317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
    Forsberg S; Ostman A; Rollman O
    Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrphostins suppress the growth of psoriatic keratinocytes.
    Ben-Bassat H; Vardi DV; Gazit A; Klaus SN; Chaouat M; Hartzstark Z; Levitzki A
    Exp Dermatol; 1995 Apr; 4(2):82-8. PubMed ID: 7640880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.
    Stoll SW; Kansra S; Peshick S; Fry DW; Leopold WR; Wiesen JF; Sibilia M; Zhang T; Werb Z; Derynck R; Wagner EF; Elder JT
    Neoplasia; 2001; 3(4):339-50. PubMed ID: 11571634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation.
    Peus D; Hamacher L; Pittelkow MR
    J Invest Dermatol; 1997 Dec; 109(6):751-6. PubMed ID: 9406816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.
    Arteaga CL; Ramsey TT; Shawver LK; Guyer CA
    J Biol Chem; 1997 Sep; 272(37):23247-54. PubMed ID: 9287333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.
    Tsou HR; Mamuya N; Johnson BD; Reich MF; Gruber BC; Ye F; Nilakantan R; Shen R; Discafani C; DeBlanc R; Davis R; Koehn FE; Greenberger LM; Wang YF; Wissner A
    J Med Chem; 2001 Aug; 44(17):2719-34. PubMed ID: 11495584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tyrphostins AG494 and AG1478 on the autocrine growth regulation of A549 and DU145 cells.
    Bojko A; Reichert K; Adamczyk A; Ligęza J; Ligęza J; Klein A
    Folia Histochem Cytobiol; 2012 Jul; 50(2):186-95. PubMed ID: 22763976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation.
    Abu-Humaidan AH; Ananthoju N; Mohanty T; Sonesson A; Alberius P; Schmidtchen A; Garred P; Sørensen OE
    J Immunol; 2014 Apr; 192(7):3355-64. PubMed ID: 24591374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different growth properties in response to epidermal growth factor and interleukin-6 of primary keratinocytes derived from normal and psoriatic lesional skin.
    Oyama N; Sekimata M; Nihei Y; Iwatsuki K; Homma Y; Kaneko F
    J Dermatol Sci; 1998 Jan; 16(2):120-8. PubMed ID: 9459124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
    Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
    Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
    Bruch-Gerharz D; Schnorr O; Suschek C; Beck KF; Pfeilschifter J; Ruzicka T; Kolb-Bachofen V
    Am J Pathol; 2003 Jan; 162(1):203-11. PubMed ID: 12507903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes.
    Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Shlomai Z; Kleinberger-Doron N; Gazit A; Plowman G; Levitzki R; Tsvieli R; Levitzki A
    Cancer Res; 1997 Sep; 57(17):3741-50. PubMed ID: 9288782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells.
    Egeblad M; Mortensen OH; van Kempen LC; Jäättelä M
    Biochem Biophys Res Commun; 2001 Feb; 281(1):25-31. PubMed ID: 11178955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions.
    Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ
    Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetic characterization of cultured human keratinocytes from normal and psoriatic individuals.
    van Ruissen F; de Jongh GJ; van Erp PE; Boezeman JB; Schalkwijk J
    J Cell Physiol; 1996 Sep; 168(3):684-94. PubMed ID: 8816923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.